Completed
Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
NCT05592418
- Conditions
- COVID-19, Chronic Disease, Coronaviridae Infections, +17 more
- Locations
-
- Hope Clinical Research Canoga Park, California, United States
- 310 Clinical Research Inglewood, California, United States
- Acclaim Clinical Research San Diego, California, United States
- Alfa Medical Research Davie, Florida, United States